BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 27143961)

  • 1. 308-nm excimer light is effective for palmoplantar pustulosis regardless of the presence or absence of focal infection: Single-center real-world experience of treatment for palmoplantar pustulosis.
    Niimura Y; Kamata M; Ishikawa T; Nagata M; Ito M; Watanabe A; Egawa S; Uchida H; Hiura A; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Tada Y
    J Dermatol; 2024 Jul; 51(7):977-984. PubMed ID: 38483008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy for palmoplantar pustulosis: A case report.
    Huang J; Wu M; Wang H
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103829. PubMed ID: 37806607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrospective study of the clinical significance of the neutrophil-to-lymphocyte ratio in 79 patients with palmoplantar pustulosis.
    Watanabe T; Watanabe Y; Asai C; Asami M; Takamura N; Yamaguchi Y
    J Dermatol; 2024 May; ():. PubMed ID: 38760982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study.
    Okubo Y; Terui T; Kobayashi S; Sano S; Morita A; Imafuku S; Tada Y; Abe M; Yaguchi M; Kimura T; Shimauchi J; Zhang W; Amouzadeh H; Murakami M
    Dermatol Ther (Heidelb); 2024 Jun; ():. PubMed ID: 38896381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Epidemiology of Palmoplantar Pustulosis: An Analysis of Multiple Health Insurance Claims and Electronic Health Records Databases.
    Ramcharran D; Strober B; Gordon K; DeKlotz C; Fakharzadeh S; Yang YW; Swerdel J; Hardin J; Dronavalli S; Paller AS
    Adv Ther; 2023 Nov; 40(11):5090-5101. PubMed ID: 37737889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palmoplantar Pustulosis: Recent Advances in Etiopathogenesis and Emerging Treatments.
    Misiak-Galazka M; Zozula J; Rudnicka L
    Am J Clin Dermatol; 2020 Jun; 21(3):355-370. PubMed ID: 32008176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apremilast monotherapy for palmoplantar pustulosis: Report of three cases.
    Marovt M; Marko PB
    SAGE Open Med Case Rep; 2021; 9():2050313X211034926. PubMed ID: 34394938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genome-wide meta-analysis of palmoplantar pustulosis implicates T
    Hernandez-Cordero A; Thomas L; Smail A; Lim ZQ; Saklatvala JR; Chung R; Curtis CJ; Baum P; Visvanathan S; Burden AD; Cooper HL; Dunnill G; Griffiths CEM; Levell NJ; Parslew R; Reynolds NJ; Wahie S; Warren RB; Wright A; ; Simpson M; Hveem K; Barker JN; Dand N; Løset M; Smith CH; Capon F
    J Allergy Clin Immunol; 2024 May; ():. PubMed ID: 38815935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin Symptoms That Appeared after Fixation with a Titanium Plate in a Jaw Deformity Patient Suffering from Palmoplantar Pustulosis: A Case Report.
    Obayashi F; Koizumi K; Ito N; Obayashi N; Shintani T; Kajiya M; Yanamoto S
    Dent J (Basel); 2023 Nov; 11(11):. PubMed ID: 37999021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apremilast is a potentially useful treatment for severe palmoplantar pustulosis with extra-palmoplantar symptoms.
    Fukushima-Nomura A; Takamiyagi S; Kakuta R; Ito Y; Hirai I; Umemoto J; Hanaoka H; Kaneko Y; Tanese K
    Skin Health Dis; 2024 Apr; 4(2):e336. PubMed ID: 38577036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted immunotherapy for moderate-to-severe palmoplantar pustulosis: a network meta-analysis of randomized controlled trials.
    Tsai YC; Hsu FL; Tsai TF
    J Am Acad Dermatol; 2024 Jul; ():. PubMed ID: 38972483
    [No Abstract]   [Full Text] [Related]  

  • 12. Research progress on the role of macrophages in acne and regulation by natural plant products.
    Zhao D; Wang Y; Wu S; Ji X; Gong K; Zheng H; Zhu M
    Front Immunol; 2024; 15():1383263. PubMed ID: 38736879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmoplantar Pustulosis: A Systematic Review of Risk Factors and Therapies.
    Heidemeyer K; May Lee M; Cazzaniga S; Yawalkar N; Naldi L
    Psoriasis (Auckl); 2023; 13():33-58. PubMed ID: 37772169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sakuranetin downregulates inducible nitric oxide synthase expression by affecting interleukin-1 receptor and CCAAT/enhancer-binding protein β.
    Yamauchi Y; Okuyama T; Ishii T; Okumura T; Ikeya Y; Nishizawa M
    J Nat Med; 2019 Mar; 73(2):353-368. PubMed ID: 30467676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Human Kallikrein 5 Protease by Triterpenoids from Natural Sources.
    Matsubara Y; Matsumoto T; Koseki J; Kaneko A; Aiba S; Yamasaki K
    Molecules; 2017 Oct; 22(11):. PubMed ID: 29077044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of combination treatment of herbal medicines and oral antihistamines for atopic dermatitis: a retrospective chart review.
    Yun Y; Son J; Kim K; Jang BH; Choi I; Ko SG
    Integr Med Res; 2017 Mar; 6(1):19-25. PubMed ID: 28462140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jumihaidokuto (Shi-Wei-Ba-Du-Tang), a Kampo Formula, Decreases the Disease Activity of Palmoplantar Pustulosis.
    Mizawa M; Makino T; Inami C; Shimizu T
    Dermatol Res Pract; 2016; 2016():4060673. PubMed ID: 27143961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local injection of micro-dose anti-interleukin-17A antibody for palmoplantar pustulosis: A real-world study.
    Xia R; Liu J; Gao Y; Diao Z; Chen D; Zhou C; Zhang Z; Yin Z
    Clin Immunol; 2023 Aug; 253():109694. PubMed ID: 37433424
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.